COPD PBMC

COPD PBMC

About:COPD PBMC are sourced from consented donors with documented chronic obstructive pulmonary disease (COPD). These samples support immune-cell research, with donor information on condition, demographics, medications and comorbidities.

All filters

Format

Format

Format
Volume / Size

Volume / Size

Volume / Size
Condition

Condition

Condition

Start typing to see matching condition.

Donor Demographics

Donor Demographics

Gender
Age Range
Race / Ethnicity

Start typing to see matching race / ethnicity.

Country of Collection
Medical History

Medical History

Medications

Start typing to see matching medications.

Comorbidities

Start typing to see matching comorbidities.

Allergy List

Start typing to see matching allergy list.

Lab Results, HLA, & Testing

Lab Results, HLA, & Testing

HLA Typing
HLA-A
HLA-B
HLA-C
HLA-DRB1
HLA-DRB4
HLA-DQA1
HLA-DQB1
HLA-DPA1
HLA-DPB1
ABO Type
Rh Type
CMV Status
HIV/HBV/HCV Tested
Syphilis Tested
Flow Data

Flow Data

Has Flow Data
Viable CD45+ (% of singlets)
CD3+ T cells (% of viable CD45+)
CD4+CD8− (% of viable CD45+)
CD4−CD8+ (% of viable CD45+)
CD3−CD16/56+ NK (% of viable CD45+)
CD19+ B cells (% of viable CD45+)
CD14+ monocytes (% of viable CD45+)
Lifestyle

Lifestyle

Tobacco Use
Alcohol Use
Recreational Drug Use
Caffeine Use
Find by ID

Find by ID

Lot #

Start typing to see matching lot #.

Patient ID

Start typing to see matching patient id.

14 lots match
14 lots available
Specimen IDSample TypeBag SizeCells / VolumePrimary DiseaseDiagnosisAllergiesAllergy ListHas Food AllergiesBMICMV StatusHIV/HBV/HCV TestedSyphilis TestedHas Infectious DiseaseInfectious DiseaseTobacco UseYears of SmokingPacks per DayAlcohol UseRecreational Drug UseCaffeine UseABO TypeRh TypeViable CD45+ (% of singlets)CD3+ T cells (% of viable CD45+)CD4+CD8− (% of viable CD45+)CD4−CD8+ (% of viable CD45+)CD3−CD16/56+ NK (% of viable CD45+)CD19+ B cells (% of viable CD45+)CD14+ monocytes (% of viable CD45+)Sample StatusAvailability
Chronic Obstructive Pulmonary Disease (COPD) PBMC 76955 151713 Male 46-60 Caucasian Cryopreserved 1 mL 122 50M Plaquenil 200mg BID Folic Acid 1mg BID Duloxetine 60mg BID Omeprazole 20mg QD Methotrexate 25mg injection, 1mg once a week Albuterol Wixela inhaler Systemic Lupus Erythematosus (SLE), Multiple Sclerosis, Diabetes Type II, Ulcerative Colitis, Chronic Obstructive Pulmonary Disease (COPD) United States 2026 02:01:01G/32:01:01G 18:01:01G/51:01:01G 07:01:01G/15:02:01G 04:02:01G/11:04:01G 01:01:01G 03:01:01G/05:01:01G 03:01:01G/03:02:01G 01:03:01G 03:01:01G/04:01:01G 209289; 209288; 209287; 209286; 209285; 209284; 209283; 209282; 209281; 209280; 209279; 209278; 209277; 209276; 209275; 209274; 209273; 209272; 209271; 209270; 209269; 209268; 209267; 209266; 209265; 209264; 209263; 209262; 209261; 209260; 209259; 209258; 209257; 209256; 209255; 209254; 209253; 209252; 209251; 209250; 209249; 209248; 209247; 209246; 209245; 209244; 209243; 209242; 209241; 209240; 209239; 209238; 209237; 209236; 209235; 209234; 209233; 209232; 209231; 209230; 209229; 209228; 209227; 209226; 209225; 209224; 209223; 209222; 209221; 209220; 209219; 209218; 209217; 209216; 209215; 209214; 209213; 209212; 209211; 209210; 209209; 209208; 209207; 209206; 209205; 209204; 209203; 209202; 209201; 209200; 209199; 209198; 209197; 209196; 209195; 209194; 209193; 209192; 209191; 209190; 209189; 209188; 209187; 209186; 209185; 209184; 209183; 209182; 209181; 209180; 209179; 209178; 209177; 209176; 209175; 209174; 209173; 209172; 209171; 209164; 209163; 209162PBMC50M cellsChronic Obstructive Pulmonary Disease (COPD)COPD;Lupus (SLE);Multiple Sclerosis;Diabetes Type 2;Ulcerative ColitisNo30.02Non ReactiveYesYesNoUsed to SmokeNoNOYesARH+StoredIn Stock
$1,109
Chronic Obstructive Pulmonary Disease (COPD) PBMC 76955 151713 Male 46-60 Caucasian Cryopreserved 1 mL 12 10M Plaquenil 200mg BID Folic Acid 1mg BID Duloxetine 60mg BID Omeprazole 20mg QD Methotrexate 25mg injection, 1mg once a week Albuterol Wixela inhaler Systemic Lupus Erythematosus (SLE), Multiple Sclerosis, Diabetes Type II, Ulcerative Colitis, Chronic Obstructive Pulmonary Disease (COPD) United States 2026 02:01:01G/32:01:01G 18:01:01G/51:01:01G 07:01:01G/15:02:01G 04:02:01G/11:04:01G 01:01:01G 03:01:01G/05:01:01G 03:01:01G/03:02:01G 01:03:01G 03:01:01G/04:01:01G 209301; 209300; 209299; 209298; 209297; 209296; 209295; 209294; 209293; 209292; 209291; 209290PBMC10M cellsChronic Obstructive Pulmonary Disease (COPD)COPD;Lupus (SLE);Multiple Sclerosis;Diabetes Type 2;Ulcerative ColitisNo30.02Non ReactiveYesYesNoUsed to SmokeNoNOYesARH+StoredIn Stock
$530
Chronic Obstructive Pulmonary Disease (COPD) PBMC 72686 117308 Male 61+ Caucasian Cryopreserved 1 mL 4 5M Lexapro Ativan .5mg PRN anxiety Remeron 45mg at bedtime Protonix 40 mg QD Amlodipine 10 mg QD Chronic Kidney Disease, Chronic Obstructive Pulmonary Disease (COPD) United States 2025 — — — — — — — — — 182340; 182341; 182342; 182343PBMC5M cellsChronic Obstructive Pulmonary Disease (COPD)COPD;Chronic Kidney DiseaseNo30.54NoNoNoUsed to Smoke351YesNOYesStoredIn Stock
$530
Chronic Obstructive Pulmonary Disease (COPD) PBMC 70414 151713 Male 46-60 Caucasian Cryopreserved 1 mL 108 50M Plaquenil 200mg BID Folic Acid 1mg BID Duloxetine 60mg BID Omeprazole 20mg QD Methotrexate 25mg injection, 1mg once a week Albuterol Wixela inhaler Systemic Lupus Erythematosus (SLE), Multiple Sclerosis, Diabetes Type II, Ulcerative Colitis, Chronic Obstructive Pulmonary Disease (COPD) United States 2025 02:01:01G/32:01:01G 18:01:01G/51:01:01G 07:01:01G/15:02:01G 04:02:01G/11:04:01G 01:01:01G 03:01:01G/05:01:01G 03:01:01G/03:02:01G 01:03:01G 03:01:01G/04:01:01G 172148; 172149; 172150; 172151; 172152; 172153; 172154; 172155; 172156; 172157; 172158; 172159; 172160; 172161; 172162; 172163; 172164; 172165; 172166; 172167; 172053; 172061; 172062; 172063; 172064; 172065; 172066; 172067; 172088; 172089; 172090; 172091; 172092; 172093; 172094; 172095; 172096; 172097; 172098; 172099; 172100; 172101; 172102; 172103; 172104; 172105; 172106; 172107; 172108; 172109; 172110; 172111; 172112; 172113; 172114; 172115; 172116; 172117; 172118; 172119; 172120; 172121; 172122; 172123; 172124; 172125; 172126; 172127; 172128; 172129; 172130; 172131; 172132; 172133; 172134; 172135; 172136; 172137; 172138; 172139; 172140; 172141; 172142; 172143; 172144; 172145; 172146; 172147; 172068; 172069; 172070; 172071; 172072; 172073; 172074; 172075; 172076; 172077; 172078; 172079; 172080; 172081; 172082; 172083; 172084; 172085; 172086; 172087PBMC50M cellsChronic Obstructive Pulmonary Disease (COPD)COPD;Lupus (SLE);Multiple Sclerosis;Diabetes Type 2;Ulcerative ColitisNo30.02Non ReactiveYesYesNoUsed to SmokeNoNOYesARH+34.9522.370.0538.71StoredIn Stock
$1,109
Chronic Obstructive Pulmonary Disease (COPD) PBMC 70518 151905 Female 46-60 Other Cryopreserved 1 mL 123 50M Diazepam 5mg BID Abilify 5mg QD Diltiazem HCl 240 mg QD Chronic Obstructive Pulmonary Disease (COPD) United States 2025 A*24:02:01:01/A*68:02:01:01 — — — — — — — — 167838; 167839; 167840; 167841; 167842; 167843; 167844; 167845; 167846; 167847; 167848; 167849; 167850; 167851; 167852; 167853; 167854; 167855; 167856; 167857; 167898; 167899; 167900; 167901; 167902; 167903; 167904; 167905; 167906; 167907; 167908; 167909; 167910; 167911; 167912; 167913; 167914; 167915; 167916; 167917; 167858; 167859; 167860; 167861; 167862; 167863; 167864; 167865; 167866; 167867; 167868; 167869; 167870; 167871; 167872; 167873; 167874; 167875; 167876; 167877; 167808; 167809; 167810; 167811; 167812; 167813; 167814; 167815; 167816; 167817; 167818; 167819; 167820; 167821; 167822; 167823; 167824; 167825; 167826; 167827; 167828; 167829; 167830; 167831; 167832; 167833; 167834; 167835; 167836; 167837; 167918; 167919; 167920; 167921; 167922; 167923; 167924; 167925; 167926; 167927; 167928; 167929; 167930; 167878; 167879; 167880; 167881; 167882; 167883; 167884; 167885; 167886; 167887; 167888; 167889; 167890; 167891; 167892; 167893; 167894; 167895; 167896; 167897PBMC50M cellsChronic Obstructive Pulmonary Disease (COPD)COPDNo30.18ReactiveYesNoNoYes-Currently Smokes400.3NoYESYesARH+StoredIn Stock
$1,109
Chronic Obstructive Pulmonary Disease (COPD) PBMC 70518 151905 Female 46-60 Other Cryopreserved 1 mL 11 10M Diazepam 5mg BID Abilify 5mg QD Diltiazem HCl 240 mg QD Chronic Obstructive Pulmonary Disease (COPD) United States 2025 A*24:02:01:01/A*68:02:01:01 — — — — — — — — 167938; 167939; 167940; 167941; 167942; 167932; 167933; 167934; 167935; 167936; 167937PBMC10M cellsChronic Obstructive Pulmonary Disease (COPD)COPDNo30.18ReactiveYesNoNoYes-Currently Smokes400.3NoYESYesARH+StoredIn Stock
$530
Chronic Obstructive Pulmonary Disease (COPD) PBMC 69549 151080 Male 61+ African American Cryopreserved 1 mL 85 50M Aspirin 81mg 1x/day Albuterol Sulfate HFA Metformin 1, 000mg BID HCTZ 25mg QD Amlodipine 5mg QD Bisoprolol 10mg QD Diabetes Type II, Chronic Obstructive Pulmonary Disease (COPD) United States 2025 A*30:02:01:01/A*30:02:01:03 — — — — — — — — 158956; 158957; 158958; 158959; 158960; 158961; 158962; 158963; 158964; 158965; 158966; 158967; 158968; 158936; 158937; 158938; 158939; 158940; 158941; 158942; 158943; 158944; 158945; 158946; 158947; 158948; 158949; 158950; 158951; 158952; 158953; 158954; 158955; 158896; 158897; 158898; 158899; 158900; 158901; 158902; 158903; 158904; 158905; 158906; 158907; 158908; 158909; 158910; 158911; 158912; 158913; 158914; 158915; 158884; 158885; 158886; 158887; 158888; 158889; 158890; 158891; 158892; 158893; 158894; 158895; 158916; 158917; 158918; 158919; 158920; 158921; 158922; 158923; 158924; 158925; 158926; 158927; 158928; 158929; 158930; 158931; 158932; 158933; 158934; 158935PBMC50M cellsChronic Obstructive Pulmonary Disease (COPD)COPD;Diabetes Type 2No21.14ReactiveYesNoYesTuberculosisUsed to SmokeYesYESYesARH+StoredIn Stock
$1,109
Chronic Obstructive Pulmonary Disease (COPD) PBMC 69593 150465 Female 46-60 Asian/Pacific Islander Cryopreserved 1 mL 60 50M Inhalers, Spiriva, BID, Wixela Inhub, rescue inhaler Combivent, cetirizine, montelukast, amlodipine, Duoneb solution, Albuterol proprium Chronic Obstructive Pulmonary Disease (COPD) United States 2025 A*02:01:01:01/A*24:02:01:01 — — — — — — — — 160908; 160909; 160910; 160911; 160912; 160913; 160914; 160915; 160916; 160917; 160918; 160919; 160920; 160921; 160922; 160923; 160924; 160925; 160926; 160927; 160928; 160929; 160930; 160931; 160932; 160933; 160934; 160935; 160936; 160937; 160938; 160939; 160940; 160941; 160942; 160943; 160944; 160945; 160946; 160947; 160948; 160949; 160950; 160951; 160952; 160953; 160954; 160955; 160956; 160957; 160958; 160959; 160960; 160961; 160962; 160963; 160964; 160965; 160906; 160907PBMC50M cellsChronic Obstructive Pulmonary Disease (COPD)COPDYesSeasonal, Pollen, Dust28.34ReactiveYesNoNoNoYesARH+StoredIn Stock
$1,109
Chronic Obstructive Pulmonary Disease (COPD) PBMC 69593 150465 Female 46-60 Asian/Pacific Islander Cryopreserved 1 mL 9 10M Inhalers, Spiriva, BID, Wixela Inhub, rescue inhaler Combivent, cetirizine, montelukast, amlodipine, Duoneb solution, Albuterol proprium Chronic Obstructive Pulmonary Disease (COPD) United States 2025 A*02:01:01:01/A*24:02:01:01 — — — — — — — — 160970; 160972; 160974; 160976; 160978; 160980; 160981; 160982; 160983PBMC10M cellsChronic Obstructive Pulmonary Disease (COPD)COPDYesSeasonal, Pollen, Dust28.34ReactiveYesNoNoNoYesARH+StoredIn Stock
$530
Chronic Obstructive Pulmonary Disease (COPD) PBMC 69549 151080 Male 61+ African American Cryopreserved 1 mL 8 10M Aspirin 81mg 1x/day Albuterol Sulfate HFA Metformin 1, 000mg BID HCTZ 25mg QD Amlodipine 5mg QD Bisoprolol 10mg QD Diabetes Type II, Chronic Obstructive Pulmonary Disease (COPD) United States 2025 A*30:02:01:01/A*30:02:01:03 — — — — — — — — 158986; 158987; 158988; 158989; 158990; 158983; 158984; 158985PBMC10M cellsChronic Obstructive Pulmonary Disease (COPD)COPD;Diabetes Type 2No21.14ReactiveYesNoYesTuberculosisUsed to SmokeYesYESYesARH+StoredIn Stock
$530
Chronic Obstructive Pulmonary Disease (COPD) PBMC 65683 146776 Female 61+ Caucasian Cryopreserved 1 mL 1 10M trelergy QD 110mcg fluoxetine 20mg QD thyroid armor 90mg QD albuterol inhaler PRN Chronic Obstructive Pulmonary Disease (COPD) United States 2025 — — — — — — — — — 72969PBMC10M cellsChronic Obstructive Pulmonary Disease (COPD)COPDNo39.7NoNoNoUsed to Smoke301.3NoNONoStoredIn Stock
$530
Chronic Obstructive Pulmonary Disease (COPD) PBMC 63742 139514 Male 61+ Hispanic/Latino Cryopreserved 1 mL 98 50M — Chronic Obstructive Pulmonary Disease (COPD) United States 2025 02:11:01:01/03:01:01:01 — — — — — — — — 66049; 66050; 66051; 66052; 66053; 66054; 66055; 66056; 66057; 66058; 66059; 66060; 66061; 66062; 66063; 66064; 66065; 66066; 66067; 66068; 66029; 66030; 66031; 66032; 66033; 66034; 66035; 66036; 66037; 66038; 66039; 66040; 66041; 66042; 66043; 66044; 66045; 66046; 66047; 66048; 66069; 66070; 66071; 66072; 66073; 66074; 66075; 66076; 66077; 66078; 66079; 66080; 66081; 66082; 66083; 66084; 66085; 66086; 66087; 66088; 66009; 66010; 66011; 66012; 66013; 66014; 66015; 66016; 66017; 66018; 66019; 66020; 66021; 66022; 66023; 66024; 66025; 66026; 66027; 66028; 65997; 65998; 65999; 66000; 66001; 66002; 66003; 66004; 66005; 66006; 66007; 66008; 66089; 66090; 66091; 66092; 66093; 66094PBMC50M cellsChronic Obstructive Pulmonary Disease (COPD)COPDNo32.28ReactiveYesNoNoYes-Currently Smokes201NoNOYesStoredIn Stock
$1,109
Chronic Obstructive Pulmonary Disease (COPD) PBMC 63742 139514 Male 61+ Hispanic/Latino Cryopreserved 1 mL 9 10M — Chronic Obstructive Pulmonary Disease (COPD) United States 2025 02:11:01:01/03:01:01:01 — — — — — — — — 65986; 65987; 65988; 65989; 65990; 65991; 65992; 65993; 65994PBMC10M cellsChronic Obstructive Pulmonary Disease (COPD)COPDNo32.28ReactiveYesNoNoYes-Currently Smokes201NoNOYesStoredIn Stock
$530
Chronic Obstructive Pulmonary Disease (COPD) PBMC 62370 146288 Female 46-60 Caucasian Cryopreserved 1 mL 1 10M hydrocortizine 30mg BID methocarbonal QD 50mg norco PRN 325mg albuterol inhaler PRN Chronic Obstructive Pulmonary Disease (COPD) United States 2025 — — — — — — — — — 63877PBMC10M cellsChronic Obstructive Pulmonary Disease (COPD)COPDNo23.24NoNoNoYes-Currently Smokes0.5NoNOYesStoredIn Stock
$530

Showing 1–14 of 14 lots

About COPD PBMC

COPD PBMC are sourced from consented donors with documented chronic obstructive pulmonary disease (COPD). These samples support immune-cell research, with donor information on condition, demographics, medications and comorbidities.

Applications

  • Chronic Obstructive Pulmonary Disease (COPD) research
  • Immune-cell phenotyping
  • Cellular functional assays
  • Single-cell and bulk transcriptomics
  • Drug-response research

Product Features

  • Peripheral blood mononuclear cells
  • Donor condition: Chronic Obstructive Pulmonary Disease (COPD)
  • Consented donor collection
  • Research Use Only (RUO)

De-identified Donor Data

  • Donor condition/diagnosis and documented clinical phenotype
  • Age, gender and race/ethnicity
  • Medications and comorbidities
  • HLA typing and CMV status
  • HIV, HBV, HCV and syphilis testing
  • ABO/Rh blood type and country of collection
  • Tobacco, alcohol, caffeine and recreational drug use

Protocols & Documentation

  • PBMC Isolation from Whole Blood

    Standard operating procedure for isolating peripheral blood mononuclear cells from whole blood using density-gradient separation.

    Download

  • Immune Cell Isolation

    Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.

    Download

  • Choosing the Right PBMC Configuration

    Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.

    Download

  • Thawing Cryopreserved PBMC

    Validated thawing protocol to recover viable cryopreserved PBMCs while minimizing activation and loss of function.

    Download

  • Informed Consent Form (ICF)

    Available upon request — confirms donor consent for research use and downstream commercialization.

PBMC

Where can I find your complete catalog?

You can find our full product catalog here.

How long can samples be stored?

Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.

What customization options are available?

Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.

Do you offer prospective collections?

Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.

What is the turnaround time for custom collections?

Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.

Do you have samples in stock?

YES - we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.

What does unique donor mean?

Each sample from a different individual - Unique donor means each sample comes from a different person, ensuring biological diversity in your study.

Are samples collected under IRB-approved protocols?

YES - "IRB-approved collection protocols" and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.

Frequently Asked Questions

×

Ask a Question

Pair with a Healthy Control

Match your COPD PBMC with normal donor samples for comparison

Healthy Donor PBMCs

733 In Stock Screened normal donors · Cryopreserved · Starting at $205 View Inventory

Related Products

Explore complementary biospecimens

View all
Inventory

Chronic Obstructive Pulmonary Disease Bulk Plasma

Format: Fresh

Volume: 50ML, 100ML, 150ML

View Product Select options
Inventory

COPD Leukopak

Format: Cryopreserved, Fresh

View Product Select options
Inventory

COPD Plasma

Format: Frozen

Volume: 1ML

View Product
Inventory

COPD Serum

Format: Frozen

Volume: 1ML

View Product
Inventory

COPD Whole Blood

Format: Fresh

Volume: 20ML, 40ML, 70ML, 60ML, 100ML

View Product Select options
Inventory

Small Cell Lung Cancer PBMC

Format: Cryopreserved

Volume: 1 x 10^7 cells (vial)

View Product
Inventory

Glioblastoma PBMC

Format: Cryopreserved

Volume: 1 x 10^7 cells (vial)

View Product
Inventory

Gastric Cancer PBMC

Format: Cryopreserved

Volume: 1 x 10^7 cells (vial)

View Product

Need a custom PBMC cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information